Back
Sep 30
Education

EDU 36 - KASTRO/KOSRO Joint Session: Radiation Therapy for Nonmalignant Disease: Transcontinental Perspectives on Newer Indications from Korea and the United States

08:00am - 09:00am PT

MODERATOR(S)

Stella Yoo, MD - LAC+USC Medical Center

session DESCRIPTION

While best known for its use in cancer, radiotherapy (RT) can be used as a successful treatment for several nonmalignant diseases. Nonetheless, the use of non-oncological RT is uncommon, and its utilization varies from country to country. Even though the use of RT for nonmalignant disease has been investigated since the discovery of X-ray, new indications are being explored, especially with the development of new technologies. Jointly sponsored by the Korean American Society for Therapeutic Radiation Oncology (KASTRO) and the Korean Society for Radiation Oncology (KOSRO), this session aims to share transcontinental perspectives from Korea and the United States on emerging areas of RT use for nonmalignant disease, including refractory osteoarthritis, Alzheimers disease, and refractory ventricular tachycardia. This session is particularly timely given the aging population of patients suffering from these conditions, with Korean researchers leading efforts to develop new whole-brain RT delivery technology for Alzheimers disease. In addition to a discussion of current evidence and future research opportunities, practical considerations for equitable patient selection, optimal treatment planning/delivery, and program development in diverse academic and community settings in two different countries will be explored.

learning objectives

  1. Learners will identify the benefits and limitations of low-dose irradiation for osteoarthritis and be refreshed with practice guidelines.
  2. Learners will identify the benefits and limitations of low-dose irradiation for neurodegenerative disease and explore its technological development and clinical use.
  3. Learners will identify the challenges and potential benefits of radioablation for refractory arrhythmia and discuss technological advancement leading to the expansion of non-oncologic RT indications.

Credits

AMA PRA Category 1 Credits: 1.00

Presentations